At a Glance
| Phosphatidylserine | PQQ | |
|---|---|---|
| Class | Nootropic, Neuroprotective | Nootropic, Neuroprotective, Mitochondrial biogenesis promoter |
| Common Dose (oral) | 200–400 mg | 10–20 mg |
| Routes | Oral | Oral |
| Effects | 2 documented | 2 documented |
Phosphatidylserine, a Nootropic, Neuroprotective, and PQQ, a Nootropic, Neuroprotective, Mitochondrial biogenesis promoter, are frequently compared by users looking to understand their relative effects, dosage profiles, and safety considerations. Phosphatidylserine is classified as a Nootropic, Neuroprotective while PQQ is a Nootropic, Neuroprotective, Mitochondrial biogenesis promoter, meaning they approach altered states through different pharmacological mechanisms. They share 1 documented effects in common, with 1 effects unique to Phosphatidylserine and 1 unique to PQQ. This side-by-side comparison covers dosage, duration, subjective effects, and safety to help you make informed decisions.
| Phosphatidylserine | PQQ | |
|---|---|---|
| Class | Nootropic, Neuroprotective | Nootropic, Neuroprotective, Mitochondrial biogenesis promoter |
| Common Dose (oral) | 200–400 mg | 10–20 mg |
| Routes | Oral | Oral |
| Effects | 2 documented | 2 documented |
| Level | Phosphatidylserine | PQQ |
|---|---|---|
| Light | 100–200 mg | 5–10 mg |
| Common | 200–400 mg | 10–20 mg |
| Strong | 400–600 mg | 20–40 mg |
| Heavy | — mg | 80 mg |
Phosphatidylserine
PQQ
No direct interaction data available between these substances. This does not mean the combination is safe.
No dangerous interactions recorded.
No dangerous interactions recorded.